Wells Fargo
KRTX

Wells Fargo’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Wells Fargo’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-28,214
Closed -$8.93M – 7766
2023
Q4 		$8.93M Sell
28,214
-9,534
-25% -$1.85M ﹤0.01% 1791
2023
Q3 		$6.38M Buy
37,748
+1,679
+5% +$316K ﹤0.01% 1935
2023
Q2 		$7.82M Sell
36,069
-3,720
-9% -$797K ﹤0.01% 1783
2023
Q1 		$7.23M Buy
39,789
+19,271
+94% +$3.69M ﹤0.01% 1826
2022
Q4 		$4.03M Buy
20,518
+5,247
+34% +$1.13M ﹤0.01% 2234
2022
Q3 		$3.44M Buy
15,271
+10,557
+224% +$2.14M ﹤0.01% 2273
2022
Q2 		$596K Sell
4,714
-9,437
-67% -$1.08M ﹤0.01% 3639
2022
Q1 		$1.79M Sell
14,151
-7,355
-34% -$828K ﹤0.01% 3399
2021
Q4 		$2.82M Buy
21,506
+10,700
+99% +$1.38M ﹤0.01% 3154
2021
Q3 		$1.32M Buy
10,806
+4,472
+71% +$516K ﹤0.01% 4008
2021
Q2 		$723K Sell
6,334
-2,742
-30% -$321K ﹤0.01% 4422
2021
Q1 		$1.09M Sell
9,076
-10,117
-53% -$1.15M ﹤0.01% 4180
2020
Q4 		$1.95M Buy
19,193
+1,772
+10% +$164K ﹤0.01% 3517
2020
Q3 		$1.35M Buy
17,421
+2,553
+17% +$218K ﹤0.01% 3633
2020
Q2 		$1.66M Buy
14,868
+4,571
+44% +$397K ﹤0.01% 3403
2020
Q1 		$742K Buy
10,297
+8,274
+409% +$708K ﹤0.01% 3741
2019
Q4 		$152K Sell
2,023
-2,745
-58% -$120K ﹤0.01% 5112
2019
Q3 		$78K Buy
+4,768
New +$92.7K ﹤0.01% 5421

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Wells Fargo's KRTX Position: Q1 2024 in Review

Wells Fargo sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 28,214 shares — an estimated $8.93M sold.

Wells Fargo first reported a position in KRTX in Q3 2019 and held it in 18 quarters. The position peaked at $8.93M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Wells Fargo reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Wells Fargo sold 28,214 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $8.93M.
  • Wells Fargo first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2019 and held it in 18 quarters.
  • Wells Fargo's Karuna Therapeutics, Inc. Common Stock position peaked at $8.93M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Wells Fargo's 13F filing for Q1 2024, filed 10 May 2024.